Brian Layden is an Endocrinology/Metabolic physician affiliated with University of Illinois Chicago. OpenAlex indexes 225 publications with 6,342 citations (h-index 45).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
303 E Chicago Ave
Tarry Building, 15th Floor
Chicago, IL 606114296
Telephone
312-695-3095Registry record last updated 12 Mar 2014.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20253 payments
- Novo Nordisk IncProgram year20252 payments
- Amgen Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
56.2%l-Thyroxine35.6%Levothyroxine Sodium100%Part D≥11 patientsParathyroid Hormone Analog11.6%Teriparatide100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
43.8%GLP-1 receptor agonist28.1%Trulicity61%Ozempic39%Part D<11 patientsVitamin D3 Analog8.2%Calcitriol100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Mechanisms of diabetes from acute pancreatitis
University of Illinois at Chicago
FY2026$477,509U01DK127378 - Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
University of Illinois at Chicago
FY2025$477,509U01DK127378 - Engineering In Vitro Models of Pregnancy-Induced Liver Changes
University of Illinois at Chicago
FY2025$440,908R21HD116135
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Jerry Krishnan, MD
University of Illinois Chicago
John Daugirdas, MD
University of Illinois Chicago
Itishree Trivedi, MD
University of Illinois Chicago
Victor Gordeuk, MD
University of Illinois Chicago
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”